Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.

Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.

Item
http://www.wikidata.org/entity/Q36142259
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragmentA phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library.Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodiesStrategies to genetically engineer T cells for cancer immunotherapy.A novel composite immunotoxin that suppresses rabies virus production by the infected cells.Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.Novel antibodies as anticancer agents.Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivoTCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.
P2860

Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.

Item
http://www.wikidata.org/entity/Q36142259
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Peptide-specific killing of an ...... ell receptor-like specificity.
@ast
Peptide-specific killing of an ...... ell receptor-like specificity.
@en
type
label
Peptide-specific killing of an ...... ell receptor-like specificity.
@ast
Peptide-specific killing of an ...... ell receptor-like specificity.
@en
prefLabel
Peptide-specific killing of an ...... ell receptor-like specificity.
@ast
Peptide-specific killing of an ...... ell receptor-like specificity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Peptide-specific killing of an ...... ell receptor-like specificity.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932